Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study

The Journal of Infection
Yu-Chia ChangNicole Huang

Abstract

It remains unclear whether pneumococcal vaccine provides additional protection to the elderly who have already vaccinated with influenza vaccine. This retrospective cohort study aimed to assess the additive effect of pneumococcal and influenza vaccines on the risk of mortality, hospitalization, and inpatient expenditure in the elderly aged 75 years or older in Taiwan. Data were extracted from the National Health Insurance claims data of a nationally representative elderly sample. To reduce potential selection bias, we employed a propensity score matching method to classify the vaccination status into 3 groups. Multivariable logistic and linear regression models were used to compare the outcomes among different groups. Each group contained 8142 subjects. The results indicated that an additive effect of receiving both vaccines was associated with a significantly lower all-cause mortality (relative risk [RR]: 0.74; 95% confidence interval [CI]: 0.57-0.96), hospitalization of all diseases including pneumonia, influenza, chronic obstructive pulmonary disease, respiratory diseases, and congestive heart disease (RR: 0.77; 95% CI: 0.67-0.90), and a 13% reduction (95% CI: 0.81-0.94) in inpatient expenditures of all diseases when compare...Continue Reading

References

Feb 7, 1996·JAMA : the Journal of the American Medical Association·J ClemensC Lowe
Feb 6, 1997·Health Policy·T L Chiang
May 31, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Y Deguchi, K Nishimura
Apr 4, 2003·The New England Journal of Medicine·Kristin L NicholMarika Iwane
Apr 7, 2004·The European Respiratory Journal·B ChristensonA Ortqvist
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chong-Shan WangPesus Chou
Nov 14, 2006·Vaccine·Chong-Shan WangPesus Chou
Mar 30, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yi-Wen TsaiPei-Fen Chen
Sep 28, 2007·The Lancet Infectious Diseases·Lone SimonsenLisa A Jackson
Oct 5, 2007·The New England Journal of Medicine·Kristin L NicholEelko Hak
Apr 30, 2008·Virology Journal·Brith ChristensonStaffan P E Sylvan
May 20, 2008·Journal of Health Economics·Hsien-Ming LienJin-Tan Liu
Aug 6, 2008·Emerging Infectious Diseases·Ravindra K GuptaJonathan S Nguyen-Van-Tam
Aug 6, 2008·Emerging Infectious Diseases·John F Brundage, G Dennis Shanks
Aug 18, 2009·Vaccine·Keith P KlugmanShabir A Madhi
Dec 25, 2009·The New England Journal of Medicine·Yu-Wen ChienDavid M Morens
Oct 5, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ivan F N HungKwok-Yung Yuen

❮ Previous
Next ❯

Citations

Oct 8, 2013·The Journal of Infection·Han Na ShinEun-Cheol Park
Apr 5, 2013·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Jeannette Y Wick
Mar 27, 2013·Enfermedades infecciosas y microbiología clínica·Francisco López-MedranoUNKNOWN Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbio
Feb 28, 2013·Human Vaccines & Immunotherapeutics·Aba MahamatBenoît de Wzieres
Apr 6, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Alfonso Rosado BuzzoJosé Manuel Sobrino Soldevilla
Sep 26, 2014·European Journal of Preventive Cardiology·Charalambos V VlachopoulosChristodoulos I Stefanadis
Aug 15, 2015·Clinical and Experimental Vaccine Research·Sung-Hsi WeiCheng-Hsun Chiu
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Sarah MoberleyRoss M Andrews
Nov 1, 2017·PloS One·Elizabeth T Cafiero-FonsecaDavid E Bloom
Sep 12, 2014·Expert Review of Vaccines·Ioanna ChristopoulouXavier Saelens
Jan 25, 2017·The Cochrane Database of Systematic Reviews·Julia Ae WaltersRichard Wood-Baker
Apr 2, 2020·Aging Medicine·Qiong ChenUNKNOWN Recommendations for Influenza, Streptococcus pneumoniae Vaccination in Elderly People in China Writing Group, Geriatric Resp
Jul 21, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Josephine StorchUNKNOWN Vaccination 60+ Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.